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Abstract 
Background:  Allergic rhinitis and asthma as single entities affect more boys than girls in childhood but more 
females in adulthood. However, it is unclear if this prevalence sex-shift also occurs in allergic rhinitis and concurrent 
asthma. Thus, our aim was to compare sex-specific differences in the prevalence of coexisting allergic rhinitis and 
asthma in childhood, adolescence and adulthood.
Methods: Post-hoc analysis of systematic review with meta-analysis concerning sex-specific prevalence of allergic 
rhinitis. Using random-effects meta-analysis, we assessed male–female ratios for coexisting allergic rhinitis and asthma 
in children (0–10 years), adolescents (11–17) and adults (> 17). Electronic searches were performed using MEDLINE 
and EMBASE for the time period 2000–2014. We included population-based observational studies, reporting coexist-
ing allergic rhinitis and asthma as outcome stratified by sex. We excluded non-original or non-population-based stud-
ies, studies with only male or female participants or selective patient collectives.
Results: From a total of 6539 citations, 10 studies with a total of 93,483 participants met the inclusion criteria. The 
male–female ratios (95% CI) for coexisting allergic rhinitis and asthma were 1.65 (1.52; 1.78) in children (N = 6 stud-
ies), 0.61 (0.51; 0.72) in adolescents (N = 2) and 1.03 (0.79; 1.35) in adults (N = 2). Male–female ratios for allergic rhinitis 
only were 1.25 (1.19; 1.32, N = 5) in children, 0.80 (0.71; 0.89, N = 2) in adolescents and 0.98 (0.74; 1.30, N = 2) in 
adults, respectively.
Conclusions: The prevalence of coexisting allergic rhinitis and asthma shows a clear male predominance in child-
hood and seems to switch to a female predominance in adolescents. This switch was less pronounced for allergic 
rhinitis only.
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Background
Increasing prevalence in allergic diseases has been 
observed in many countries, especially in Western but 
also many developing countries [1]. Sex specific differ-
ences in prevalence of allergic rhinitis and asthma over 
the life span were recognized, showing a higher preva-
lence of allergic rhinitis and asthma as single entities 
in boys than in girls during childhood followed by an 
equal distribution in adolescence [2, 3]. In adulthood 
more women than men are affected by asthma [4, 5]. In 
a prospective cohort study, the prevalence of coexisting 
eczema, allergic rhinitis, and asthma in the same child 
was more common than expected by chance alone and 
was not only attributable to IgE sensitization, suggest-
ing that these diseases share causal mechanisms [6]. In a 
systematic review of studies across the globe we showed 
a sex-switch in prevalence of allergic rhinitis in popula-
tion-based studies [3]. Since research on multimorbid-
ity, i.e. the coexistence of 2 or more allergic diseases in 
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the same individual, is sparse, the aim of this systematic 
review with meta-analyses was to examine sex specific 
differences in the prevalence of coexisting allergic rhini-
tis and asthma, from childhood through adolescence into 
adulthood.
Methods
Data sources, search strategy, and selection criteria
We conducted a systematic literature search using the 
online databases MEDLINE and EMBASE. MeSH terms 
were used in conjunction with keywords searched in 
the title and abstract. We restricted our search to stud-
ies published between January 2000 and April 2014. 
There was no restriction to the language of publica-
tion. The protocol for our systematic review was devel-
oped with guidance from the Preferred Reporting Items 
for Systematic Review and Meta-Analysis (PRISMA) 
statement [7]. It can be accessed at PROSPERO (http://
www.crd.york.ac.uk/PROSPERO/, registration number 
CRD42016036105). To manage the identified publica-
tions, we used EndNote  X7® (Thomson Reuters) biblio-
graphic database.
Inclusion and exclusion criteria
The selection of studies was performed along with pre-set 
criteria for in- or exclusion. Since the present study is a 
post hoc analysis of a larger review considering the differ-
ence in prevalence for allergic rhinitis only [3], we chose 
broad inclusion criteria to reach most of the available 
information and to increase generalisability. The present 
analysis included studies of the previous comprehensive 
review that (1) recruited participants of both sexes from 
the general population, (2) reported the prevalence of 
coexisting allergic rhinitis and asthma, asthma only, and 
allergic rhinitis only stratified by sex and age if the popula-
tion under study included both children and adults, and (3) 
were designed as longitudinal or cross-sectional studies.
We excluded (1) non-original studies (e.g. reviews or 
guidelines), (2) studies that selected participants by spe-
cial occupation, (3) studies with only male or female 
participants, (4) studies analysing selective patient col-
lectives (e.g. from special allergy clinics), or (5) non-pop-
ulation-based study designs e.g. ecological studies, case 
reports, case series, case–control studies, experimental 
studies, intervention studies, and clinical studies.
We evaluated prevalence estimates of allergic rhini-
tis, asthma and coexisting allergic rhinitis and asthma 
regarding the following endpoints: allergic rhinitis only 
was defined as having symptoms of allergic rhinitis (i.e. 
runny nose without having a cold) without having symp-
toms of asthma. In analogy, asthma only was defined as 
having symptoms of asthma (i.e. wheezing or whistling 
in the chest) but no symptoms of allergic rhinitis. An 
individual who named both symptoms of allergic rhini-
tis and symptoms of asthma was included in the group of 
coexisting allergic rhinitis and asthma. If selected studies 
reported prevalence rates for having symptoms ever or 
current, we chose ‘current’, which was defined as report-
ing symptoms in the last 12 months.
Study selection, data extraction and quality assessment
A detailed protocol of the selection process for the ini-
tial review was published elsewhere [3]. In short a two-
step review process was performed with scanning titles 
of identified studies first independently by two review-
ers (MP and CH), followed by a second screening of all 
abstracts of articles rated as ‘include’ or ‘unclear’. A disa-
greement between the two reviewers was resolved by 
discussion to meet a consensus. If consensus was not 
reached, a third independent reviewer (TKei or MF) was 
asked to assess the relevance.
Prior to data extraction, two reviewers (MP and MF) 
independently reviewed full texts of all selected publica-
tions rated as ‘include’ or ‘unclear’. A pre-designed data 
extraction form was piloted with five studies selected 
from the pool of included studies. At least two review-
ers (TKel, CH, BC, TKei, AR, MP and MF) extracted data 
from the selected full texts independently with disagree-
ments through referral to a third reviewer (TKei).
For data extraction we used a self-designed (MP) SoSci-
Survey questionnaire (https://www.soscisurvey.de/) 
retrieving information on country, study design, descrip-
tion of the process of recruitment of participants, age of 
participants, sample size, residency, response rate, obser-
vation period, definition of disease and measurement, 
method of data collection, prevalence of allergic rhinitis 
only (i.e. subjects without asthma) and asthma only (i.e. 
subjects without allergic rhinitis) as well as coexisting 
allergic rhinitis and asthma stratified by sex. Prevalences 
for each study were calculated using the number of par-
ticipants with the respective disease as numerator and 
the total number of participants as denominator.
To evaluate the quality of identified literature and the 
heterogeneity between different studies we used an eval-
uation score based on previously published studies [8]. 
For this score every included article was reviewed on 
sampling method, response rate, sample size, and data 
collection method. A maximum of five points would 
account for ‘high quality’, three to four points would be 
‘moderate’ and zero to two would be ‘low quality’.
Quantitative data synthesis
Study populations were divided into age ranges of child-
hood (0–10 years of age), adolescence (11–17 years), or 
adulthood (18–79  years). For each study, we extracted 
the prevalence rates of coexisting allergic rhinitis and 
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asthma, as well as of allergic rhinitis only, and asthma 
only separately for male and female participants. We then 
calculated male–female ratios for each study, as well as 
pooled male–female-ratio estimates with 95% confidence 
intervals (95% CI) using random-effects meta-analyses 
with the inverse variance method (SR). Heterogeneity 
between the studies was measured by  I2. Statistical analy-
ses were done using Review Manager (RevMan), Ver-
sion 5.3. Copenhagen (The Nordic Cochrane Centre, The 
Cochrane Collaboration, 2014) and R (R Foundation for 
Statistical Computing, Vienna, Austria).
Results
Characteristics of included studies
1222 out of 6539 publications were selected by title screen-
ing. Of those, 247 studies were eligible for data extraction 
since they reported prevalence of allergic rhinitis strati-
fied by sex. Finally, 10 studies reporting the prevalence of 
asthma alone and allergic rhinitis with coexisting asthma 
were included into the systematic review (Fig. 1, Table 1) 
[8–16]. Six studies provided sex-specific prevalence of 
coexisting allergic rhinitis and asthma, allergic rhinitis 
only, and asthma only in children (0–10 years), two stud-
ies in adolescents (11–17 years), and two studies in adults 
(18–79 years). Studies with a broad age range were catego-
rised as closely as possible to the targeted age groups, using 
the mean age of the participants for one study [16]. The 
assessment of allergic symptoms was questionnaire-based, 
mainly using the International Study of Asthma and Aller-
gies in Childhood (ISAAC) [17] questionnaire for 8 studies 
in children and adolescents [8, 10–15, 18], or the European 
Community Respiratory Health Survey (ECRHS) [19] for 2 
studies in adults [9, 20]. See Additional file 1: Tables E1–E3 
for further description of study characteristics and Addi-
tional file 1: Table E5 for study results.
Male–female ratios of coexisting allergic rhinitis 
and asthma
We included 6 studies with a total of 34,365 males and 
31,611 females for children (0–10  years), 2 studies 
with 1803 males and 2152 females for adolescents (11–
17  years) and 2 studies with 11,573 males and 11,979 
females for adults (18–79  years). The pooled estimates 
for the male–female ratio (males vs. females) of the prev-
alence of coexisting allergic rhinitis and asthma were 1.65 
(95% CI 1.52–1.78) in children, 0.61 (0.51–0.72) in ado-
lescents, and 1.03 (0.79–1.35) in adults (Fig. 2). 
The studies reported a male predominance of coexist-
ing allergic rhinitis and asthma in children and a female 
predominance in adolescents. Desalu et al. [9] and Konno 
et al. [20] showed heterogeneous results for adulthood.
Male–female ratios of allergic rhinitis without asthma
We included 5 studies with 29,775 males and 27,071 
females for children (0–10  years), 2 studies with 1803 
males and 2152 females for adolescents (11–17 years) and 
2 studies that included 11,573 males and 11,979 females 
for adults (18–79  years). The pooled estimates for the 
male–female ratio of the prevalence of allergic rhinitis 
only were 1.25 (1.19–1.32) in children, 0.80 (0.71–0.89) in 
adolescents and 0.98 (0.74–1.30) in adults.
None of the studies reported a female predominance 
in the prevalence of allergic rhinitis only among children. 
In contrast both studies providing information on ado-
lescents showed a female predominance. Concerning the 
prevalence among adults the two analysed studies again 
showed heterogeneous results.
Male–female ratios of asthma without allergic rhinitis
We included 5 studies with 29,775 males and 27,071 
females for children (0–10  years), 2 studies with 1803 
males and 2152 females for adolescents (11–17  years). 
We found only one study providing information on 
asthma only in adults. The pooled estimates for the 
male–female-ratio of the prevalence of asthma only 
were 1.20 (0.99–1.45) in children and 1.03 (0.62–1.71) 
in adolescents. Konno et al. [20] reported in a study with 
11,132 males and 11,687 females a male–female ratio 
for the prevalence of asthma only of 1.61 (1.44–1.81) in 
adults (Fig. 3).
Four of five included studies for asthma only in children 
reported a male predominance, whereas Nahhas et  al. 
[15] showed a female predominance. Two studies ana-
lysed the prevalence of asthma only in adolescents and 
found heterogeneous results. De Brito et al. [8] reported 
a female predominance, whereas Luna et al. [14] showed 
a male predominance.
Heterogeneity and quality of studies
While no statistical heterogeneity was detected among 
the lower age groups, moderate heterogeneity existed 
among the studies in the adult group (I218–79  =  41%) 
for coexisting allergic rhinitis and asthma. In the 
meta-analysis for the prevalence of asthma only, con-
siderable heterogeneity was found (I20–10  =  75%; I211–
17 = 81%) resulting in an overall of  I2 = 85%. Little or 
no heterogeneity was seen in studies reporting results 
for allergic rhinitis only in children and adolescents 
(I20–10 = 27%; I211–17 = 0%) compared to studies includ-
ing adults (I218–79 = 73%). All studies were of moderate 
quality (4 points) except from Desalu et al., which was 
rated as high quality (5 points), see Additional file  1: 
Table E4.
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Discussion
Main findings
We found a clear ‘sex-switch’ in the prevalence of 
coexisting allergic rhinitis and asthma from a male 
predominance in childhood to a female predominance 
in adolescence. Similar trends of these sex-specific 
prevalence patterns were observed in participants with 
asthma only and those with allergic rhinitis only. Two 
Id
en
tif
ic
at
io
n
Sc
re
en
in
g
El
ig
ib
ili
ty
In
cl
ud
ed
Records identified
through PubMed
(n = 3458)
Records identified
through Embase
(n = 6494)
Records after duplicates removed
automatically by Endnote
(n = 6539)
Records selected by title
(n = 1222)
Records excluded
(n = 5317)
Full-text articles assessed for 
eligibility
(n = 900)
Full-text articles excluded (n= 653)
• Excluded (n = 425)
• Full text not available (n = 228)
Studies included for data 
extraction
(n = 247)
Studies included in quantitative 
synthesis (meta-analysis)
(n = 10)
Records excluded (n = 322)
• Pubmed (n = 176)
• Embase (n = 146)
Full-text articles excluded (n =25)
• Duplicates, removed manually 
(n= 25)
Full-text articles excluded (n =212)
• Patient population (n = 1)
• Participants selected by occupation (n = 2)
• Study design (n = 29)
• Prevalence not stratified by age (n = 17)
• Overlapping age categories (n = 25)
• Prevalence not stratified by sex (n = 30)
• Prevalence not reported (n = 70)
• Self- or parent-reported symptoms not
reported (n = 7)
• Current symptoms not reported (n = 26)
• Other (n = 5)
Fig. 1 PRISMA flow chart for literature search
Page 5 of 9Fröhlich et al. Clin Transl Allergy  (2017) 7:44 
studies in adults showed similar prevalence rates in both 
sexes.
Comparison with other studies
In a global systematic review with meta-analysis we 
showed sex-related differences in rhinitis prevalence with 
a prevalence shift from a male predominance at around 
puberty to a female predominance thereafter [3]. Simi-
larly, a retrospective analysis of the ECRHS data from 
16 European countries showed a transition for asthma 
from a male predominance in childhood (0–10  years) 
followed by an equal gender distribution in adolescence 
(10–15 years) leading to a female predominance in adults 
(>  15  years) [21]. Sex-specific rhinitis and comorbid 
asthma prevalence data for older men and women are 
very scarce. Interestingly, according to a large observa-
tional all-female cohort, the Nurses’ Health Study in USA, 
the age-adjusted risk of asthma seems to be increased 
in postmenopausal women who ever or currently used 
hormone replacement therapy (i.e. conjugated estrogens 
with or without progesterone) compared to those who 
never used such hormones. However, allergic rhinitis 
with and without comorbid asthma has not been exami-
nated [22]. In a cohort study of 509 children with allergic 
rhinitis from Turkey (mean age 7.2 ± 3.5 years, age range 
1.5–18  years) Dogru showed that asthma was prevalent 
in the majority (53.2%) of these children [23]. In a French 
observational study of patients with asthma more than 
50% of participants had concomitant allergic rhinitis [24]. 
Several narrative reviews showed this change in sex pre-
dominance favoring females during the transition from 
childhood to adulthood for diverse allergy-related dis-
eases [4, 5, 25, 26]. Therefore, and since asthma and rhini-
tis coexist more often than expected [6], we hypothesized 
that also concomitant allergic rhinitis and asthma may 
undergo a similar sex-shift in prevalence during puberty.
Our results support this hypothesis to some extent. 
However, the limited number of studies found in adults 
did not allow us to clearly establish a clear tendency 
towards a male or female predominance but rather a bal-
ance between the sexes. Our pooled estimates relied only 
upon data from studies conducted in Asia (N = 7), South 
America (N =  2) and Africa (N =  1). In Pinart et  al. a 
sex switch for allergic rhinitis prevalence around puberty 
was not found in studies conducted in Asia [3]. Five of 
six studies in the youngest age group (0–10 years) were 
from Asia, whereas no Asian studies were found for ado-
lescents (11–17 years), suggesting a considerable bias.
Concerning possible mechanisms underlying a higher 
prevalence of allergic diseases in women during and 
after adolescence, higher levels of sex hormones such as 
estrogen and progesterone were suggested to be of cen-
tral importance [27]. Sex hormones play a role in the 
homeostasis of immunity [28]. Estrogen and proges-
terone enhance type 2 and suppress type 1 responses 
in females, whereas testosterone suppresses type 2 
responses in males [29]. Experiments in rodents showed 
an effect of estrogens on mast cell activation and the 
development of allergic sensitization, while progesterone 
can suppress histamine release but potentiate IgE induc-
tion [28]. Similarly for asthma sex differences have been 
reported for different phenotypes and symptom profiles 
in epidemiological, clinical and experimental studies, 
however, the aetiology remains largely unclear [30–33].
Risk of bias
We tried to identify all population based studies report-
ing prevalence of coexisting allergic rhinitis and asthma. 
Given that such observational studies require large sam-
ples, it seems unlikely that a study of this dimension will 
have been published and not identified by our search. 
Furthermore, in population-based prevalence studies 
publication bias seems to be less of a concern than e.g. in 
interventional studies. Thus, we believe that a bias due to 
unpublished data is unlikely.
Table 1 Main characteristics of studies included in the sys-
tematic review
ISAAC International Study of Asthma and Allergies in Childhood, ECRHS 
European Community Respiratory Health Survey
Study characteristics Number of studies
Total 10
Study period
 2000–2007 7
 2008–2014 3
Region
 Africa 1
 Asia 7
 South America 2
Sample size analysed
 < 1000 2
 1001–5000 1
 5001–10,000 3
 10,001–100,000 4
Age category (in years)
 0–10 6
 11–17 2
 18–79 2
Urbanicity
 Urban 7
 Rural/urban 1
 Unclear/not reported 2
Method for assessing prevalence
 ISAAC questionnaire 8
 ECHRS questionnaire 2
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Our systematic review was embedded in a larger 
review considering the difference in prevalence for rhi-
nitis only [3]. Although we used broad inclusion criteria, 
we may have missed studies that provided information 
on prevalence of having allergic rhinitis and asthma but 
did not provide information of having allergic rhinitis 
only or were published in journals that are not listed 
in the 2 major databases of medical literature, MED-
LINE and EMBASE. Primary care-based studies includ-
ing e.g. only out-patients were excluded because of a 
possible gender-related bias considering that women 
seek medical treatment, screening programs and other 
health care offers more often than men [34]. Restricting 
our search to studies published between 2000 and 2014 
does not allow us to conclude on possibly different find-
ings from earlier studies. The prevalence of allergies has 
dramatically increased in the second half of the twen-
tieth century but reasons for these temporal trends are 
not clear [35]. We therefore wanted to avoid the rather 
speculative comparisons of prevalence studies across 5 
and more decades and focused our evaluation on the 
2 recent decades where the prevalence of allergies may 
have reached a plateau in many regions around the 
world [36].
Most of the included studies, especially in children, 
were conducted in Asia, which may limit the generalisa-
bility of the results, because of specific genetic differences 
between ethnic groups as well as different environmental 
factors for allergic diseases such as air pollution.
Our results showed that a sex switch from a male to a 
female predominance in the coexistence of allergic rhini-
tis and asthma is reported in population-based studies; 
however, further research is needed to study the under-
lying mechanisms. The definition of allergic rhinitis and 
asthma in our study is based on answers to validated 
questions from the ISAAC and ECRHS projects. Though 
these instruments are widely used globally and well vali-
dated in many languages especially for asthma, a possible 
overestimation of asthma or allergic rhinitis prevalence 
cannot be excluded. However, we do not think that this 
affects the male–female-ratios of the prevalence esti-
mates used in our analysis since there is no indication 
for different overestimation between male and female 
responders of the included questions.
Fig. 2 Forest plot estimating the difference in prevalence of current coexisting allergic rhinitis and asthma between males and females in child-
hood, adolescence and adulthood
Page 7 of 9Fröhlich et al. Clin Transl Allergy  (2017) 7:44 
Using current symptoms of asthma and allergic rhinitis 
as outcome definition may cause misclassification if clas-
sifying individuals without symptoms because of success-
ful symptom control for example as negative. However, 
we consider it unlikely that a person using e.g. anti-
obstructive medication on a daily basis would answer 
negative to the question for having wheeze during the last 
12 months. While, on the contrary, we judge the usage of 
doctor’s diagnosis to result in an underestimation of the 
number of subjects with allergic diseases.
Though there were many studies using the ISAAC study-
design only few studies fulfilled our stringent inclusion 
criteria. This shows that there is a need for a more mul-
timorbid perspective in population-based studies. For this 
work, we identified only cross-sectional studies. Although 
this study design is adequate for estimating population-
based prevalences, longitudinal studies would be of inter-
est to examine possible mechanisms underlying these 
differences in prevalence. Therefore, birth cohort studies 
in particular, are currently being evaluated regarding sex-
specific allergy prevalence differences in childhood and 
early adolescence within the MeDALL project [37, 38].
Considerable inconsistency was found solely in our 
meta-analyses for asthma only and for the 2 adult stud-
ies as indicated by the Higgins’  I2-tests. These summary 
measures of the meta-analyses should be interpreted 
with extra caution. Potential sources of heterogeneity 
include study design, study area or analysed age groups, 
but the specific influence cannot be examined due to the 
limited number of studies.
Conclusions
Based on a systematic review with meta-analysis of 
cross-sectional population-studies from across the globe 
we found a clear male predominance for the prevalence 
of coexisting allergic rhinitis and asthma in childhood. 
This seems to shift towards a female predominance in 
adolescents. Such a shift was less pronounced for aller-
gic rhinitis as a single entity. Our results suggest that the 
effect of puberty seems to be particularly present in the 
most severely affected patients who have both allergic 
rhinitis and concurrent asthma. However, sex- and gen-
der-specific evaluations beyond 14 years of age are scarce 
and further allergic multimorbidity studies in different 
Fig. 3 Forest plot estimating the difference in prevalence of allergic rhinitis only between males and females in childhood, adolescence and adult-
hood
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population settings, particularly in adults, are required. 
In clinical, epidemiological and basic research more sex- 
and gender-specific analyses are needed to develop better 
prevention and treatment strategies.
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